Tissue-specific and reversible RNA interference in transgenic mice

被引:135
作者
Dickins, Ross A.
McJunkin, Katherine
Hernando, Eva
Premsrirut, Prem K.
Krizhanovsky, Valery
Burgess, Darren J.
Kim, Sang Yong
Cordon-Cardo, Carlos
Zender, Lars
Hannon, Gregory J.
Lowe, Scott W.
机构
[1] Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA
[2] Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA
[3] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA
[4] Mem Sloan Kettering Canc Ctr, Div Mol Pathol, New York, NY 10021 USA
关键词
D O I
10.1038/ng2045
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Genetically engineered mice provide powerful tools for understanding mammalian gene function. These models traditionally rely on gene overexpression from transgenes or targeted, irreversible gene mutation. By adapting the tetracycline ( tet)- responsive system previously used for gene overexpression, we have developed a simple transgenic system to reversibly control endogenous gene expression using RNA interference ( RNAi) in mice. Transgenic mice harboring a tet- responsive RNA polymerase II promoter driving a microRNA- based short hairpin RNA targeting the tumor suppressor Trp53 reversibly express short hairpin RNA when crossed with existing mouse strains expressing general or tissue- specific 'tet- on' or 'tet- off' transactivators. Reversible Trp53 knockdown can be achieved in several tissues, and restoring Trp53 expression in lymphomas whose development is promoted by Trp53 knockdown leads to tumor regression. By leaving the target gene unaltered, this approach permits tissue- specific, reversible regulation of endogenous gene expression in vivo, with potential broad application in basic biology and drug target validation.
引用
收藏
页码:914 / 921
页数:8
相关论文
共 39 条
[1]   THE C-MYC ONCOGENE DRIVEN BY IMMUNOGLOBULIN ENHANCERS INDUCES LYMPHOID MALIGNANCY IN TRANSGENIC MICE [J].
ADAMS, JM ;
HARRIS, AW ;
PINKERT, CA ;
CORCORAN, LM ;
ALEXANDER, WS ;
CORY, S ;
PALMITER, RD ;
BRINSTER, RL .
NATURE, 1985, 318 (6046) :533-538
[2]   Validating cancer drug targets [J].
Benson, John D. ;
Chen, Ying-Nan P. ;
Cornell-Kennon, Susan A. ;
Dorsch, Marion ;
Kim, Sunkyu ;
Leszczyniecka, Magdalena ;
Sellers, William R. ;
Lengauer, Christoph .
NATURE, 2006, 441 (7092) :451-456
[3]   Gene targeting in mice: functional analysis of the mammalian genome for the twenty-first century [J].
Capecchi, MR .
NATURE REVIEWS GENETICS, 2005, 6 (06) :507-512
[4]  
Ceccarelli AV, 2002, COMPARATIVE MED, V52, P171
[5]   Conditional knockdown of Fgfr2in mice using Cre-LoxP induced RNA interference -: art. no. E102 [J].
Coumoul, X ;
Shukla, V ;
Li, CL ;
Wang, RH ;
Deng, CX .
NUCLEIC ACIDS RESEARCH, 2005, 33 (11) :1-8
[6]   Probing tumor phenotypes using stable and regulated synthetic microRNA precursors [J].
Dickins, RA ;
Hemann, MT ;
Zilfou, JT ;
Simpson, DR ;
Ibarra, I ;
Hannon, GJ ;
Lowe, SW .
NATURE GENETICS, 2005, 37 (11) :1289-1295
[7]   Reversible tumorigenesis by MYC in hematopoietic lineages [J].
Felsher, DW ;
Bishop, JM .
MOLECULAR CELL, 1999, 4 (02) :199-207
[8]   Reversibility of oncogene-induced cancer [J].
Felsher, DW .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2004, 14 (01) :37-42
[9]   Conditional gene knock-down by CRE-dependent short interfering RNAs [J].
Fritsch, L ;
Martinez, LA ;
Sekhri, R ;
Naguibneva, I ;
Gérard, M ;
Vandromme, M ;
Schaeffer, L ;
Harel-Bellan, A .
EMBO REPORTS, 2004, 5 (02) :178-182
[10]   TEMPORAL CONTROL OF GENE-EXPRESSION IN TRANSGENIC MICE BY A TETRACYCLINE-RESPONSIVE PROMOTER [J].
FURTH, PA ;
STONGE, L ;
BOGER, H ;
GRUSS, P ;
GOSSEN, M ;
KISTNER, A ;
BUJARD, H ;
HENNIGHAUSEN, L .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (20) :9302-9306